Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS ) 75.58 +0.42 (+0.56%) Streaming Delayed Price Updated: 11:27 AM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GeneDx Holdings Corp. - Class A Common Stock < Previous 1 2 3 4 5 Next > GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting November 04, 2024 From GeneDx Via Business Wire Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? November 03, 2024 Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%). Via Benzinga Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results October 29, 2024 Via Benzinga Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views October 29, 2024 Via Benzinga The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts October 16, 2024 Via Benzinga GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics September 19, 2024 The company provides sequencing tools to help diagnose children with rare diseases. Via Investor's Business Daily Expert Ratings For GeneDx Hldgs July 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 29, 2024 Via Benzinga Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance October 29, 2024 GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. Via Benzinga Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday October 29, 2024 Via Benzinga GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights October 29, 2024 From GeneDx Via Business Wire The Latest Analyst Ratings For GeneDx Hldgs June 26, 2024 Via Benzinga Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening October 24, 2024 From GeneDx Via Business Wire GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns October 08, 2024 From GeneDx Via Business Wire GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 October 03, 2024 From GeneDx Via Business Wire The Markets Are Ignoring Risk, But That Does Not Mean You Should... September 29, 2024 It is Fall clean-up time. Sell lagging and sagging companies. Via Talk Markets GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 27, 2024 From GeneDx Via Business Wire GeneDx to Participate in Fall Investor Conferences August 12, 2024 From GeneDx Via Business Wire GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 09, 2024 From GeneDx Via Business Wire WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024 July 30, 2024 WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients July 30, 2024 From GeneDx Via Business Wire GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights July 30, 2024 From GeneDx Via Business Wire GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing July 18, 2024 GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. Via Benzinga GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 July 11, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 7 Small-Cap Stocks With Massive Potential Returns July 06, 2024 Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries. Via InvestorPlace GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients June 10, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying June 06, 2024 Via Benzinga GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients June 05, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying May 29, 2024 Via Benzinga GeneDx to Participate in Upcoming Investor Conferences May 22, 2024 From GeneDx Holdings Corp. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
